Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial

Published:2019-06-25 Issue:2 Volume:25 Page:199-209
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Sharma Manoj Kumar,Kainth Sumeet,Kumar Sachin,Bhardwaj Ankit,Agarwal Hemant Kumar,Maiwall Rakhi,Jamwal Kapil Dev,Shasthry Saggere Muralikrishna,Jindal Ankur,Choudhary Ashok,Anand Lovkesh,Dhamija Rajender Mal,Kumar Guresh,Sharma Barjesh Chander,Sarin Shiv Kumar

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://e-cmh.org/upload/pdf/cmh-2018-0084.pdf

Reference25 articles.

1. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis

2. Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface

3. Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subclinical brain manifestations of repeated mild traumatic brain injury are changed by chronic exposure to sleep loss, caffeine, and sleep aids;Experimental Neurology;2024-11

2. Sleep disturbances in chronic liver disease;Liver Transplantation;2024-03-27

3. Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2024-03-10

4. Drug-facilitated sexual assault followed by femicidal chloroform poisoning and suffocation: A case-report of criminal responsibility;Legal Medicine;2024-02

5. Management of fatigue and sleep disorders in patients with chronic liver disease;Clinical Liver Disease;2024-01